Summary
Overview
Work History
Education
Skills
Languages
Awards
References
Disclaimer
Personal Information
Professional Summary
Languages
Certification
Accomplishments
References
Timeline
Generic
Kingshuk Bhattacharjee

Kingshuk Bhattacharjee

Summary

Dynamic Senior Medical Manager with a proven track record at Novo Nordisk India, leading successful product launches and managing high-performing teams. Expert in medical strategy and KOL engagement, driving significant market share growth. Adept at medical affairs, clinical trials and fostering cross-functional collaboration, ensuring compliance and innovative medical education initiatives. Resourceful professional in healthcare management known for high productivity and efficiency in task completion. Skilled in strategic planning, regulatory compliance, and patient care coordination. Excel at team leadership, problem-solving, and communication, ensuring seamless operations and quality service delivery in fast-paced environments. Knowledgeable patient representative offers demonstrated skills in case management and service coordination. Expertly handles complaints, inquiries and service questions to meet patients' access needs and correct problems related to care. Well-versed in policies, procedures and standards.

Overview

15
15
years of professional experience
1
1
Certification

Work History

Senior Medical Manager

Novo Nordisk India Pvt Ltd
08.2022 - Current
  • Leading the successful launch of oral semaglutide (Rybelsus®), achieving ~5% market share within Two and Half years through strategic medical planning and execution.
  • Managed a team of 25 medical doctors to enhance HCP engagement and drive product adoption.
  • Led and played a pivotal role in the PIONEER-REAL INDIA, CONVERGE and CAPTIVATE INDIA study, the largest RWE study for oral semaglutide in India.
  • Collaborating with cross-functional teams to develop and implement comprehensive medical plans for the GLP-1 portfolio.
  • Providing medical expertise in ongoing Phase 2 and Phase 3 clinical trials, portfolio publications, medical education initiatives.

Dimensions:

Leadership and Team Management

  • Developing and leading high-performing teams of medical managers, advisors, and regional advisors.
  • Implementing effective performance management strategies including goal setting, regular feedback, and talent development plans.
  • Cultivating a high-performance culture emphasizing professional and personal growth.
  • Identifying and nurturing high-potential talent, providing opportunities for advancement.
  • Managing team resources and performance metrics.

Medical Strategy and Execution

  • Aligning regional medical strategies with national objectives to achieve business goals.
  • Ensuring team adherence to SOPs, compliance regulations, and budgetary guidelines.
  • Leading medical initiatives and projects to drive business growth and innovation.
  • Building and maintaining strong relationships with key opinion leaders (KOLs) and healthcare professionals (HCPs).
  • Developing and executing medical education and communication plans.
  • Providing medical expertise for product launches, lifecycle management, and regulatory affairs.

Cross-Functional Collaboration

· Collaborating effectively with cross-functional teams, including sales, marketing, and regulatory affairs.

· Developing strong interpersonal and relationship-building skills.

· Influencing and building consensus among diverse stakeholdersto achieve key outcomes.

Medical Manager

Nordisk India Pvt Ltd
10.2021 - 07.2022
  • Key focus to manage and develop a team of Regional Medical Advisors (RMAs) and developing a medical strategy aligned with the overall India and Global Medical Affairs Strategy
  • Responsible for managing and developing high performing medical advisors’ team
  • Effective Performance management – Goal setting, performance dialogues and timely constructive feedback to RMAs
  • Develop and build a high performing team with effective Individual Development Plan for the team
  • Timely structured coaching sessions to the team and facilitate and drive a learning culture with a high focus on professional/personal development of the team
  • Responsible for identifying and developing high-potentials and provide platforms for learning and development
  • Liaise with regional sales, marketing, and compliance to ensure RMA team supports business requirements
  • To ensure coordination of national medical strategies with local strategies on a product/project specific basis to convey a credible and compliant scientific message to the medical community that supports the Sales organization and Novo Nordisk’s products
  • Suggest ideas and implement projects at a regional level in line with HO medical ambitions
  • Maintain strong product & therapy area knowledge for self and RMA team through journal clubs and others
  • Ensure RMA resource allocation for medical education and guidance activities
  • Guide Field interactions in adding scientific value to the visits of RMAs, conduct joint field work with RMAs
  • Ensure RMA wise national and regional KOL mapping and constant scientific engagement
  • Maintain trackers to provide insights for continuous development
  • Maintain a list of select regional and national KOLs for self and the RMAs
  • Ensure regular scientific engagement with the listed KOLs
  • Ensure medical queries are addressed timely by the RMA and off-label medical queries are addressed in a compliant manner
  • Update scientific content, MCQs, role play cases, quiz, etc
  • With training team for continuous sales scientific empowerment
  • Ensure balanced and effective scientific communication by RMAs
  • Provide inputs to business unit based on market insights
  • Explore and suggest opportunities to increase professional relationships and stronger collaboration with regional associations and KOLs
  • Maintain strong KOL relationship & facilitate RMA relations
  • Identify & engage with regional associations to plan NN symposia + National conference support
  • Facilitate conduct of advisory boards

Regional Medical Advisor

Novo Nordisk India Pvt Ltd
06.2018 - 09.2021
  • To establish leadership in diabetes and access to Novo Nordisk (NN) products in the zone through providing quality medical and scientific support to doctors (mainly influencers), other healthcare professionals (HCPs - nurses, pharmacists, etc.) and colleagues
  • The main outcome of the job is to ensure KOLs, and specialists are aware of and understand the scientific basis for and clinical usefulness of our compounds within diabetes
  • Scientific support for marketed products and development projects within diabetes
  • Productive relationships with key stakeholders and relevant institutions/organizations to achieve competitive advantage and market leadership within diabetes
  • Training and educational activities for doctors and other HCPs working with diabetes
  • Planning of Regional Medical Education activities i.e
  • Regional conferences
  • Manage discussion with the investigator
  • Manage Regional Publications, Conferences and publication plan
  • Execution of regional medical activities
  • Pre -Conference Preparation (Including Liaoning with Speaker)
  • Plan and align HCP and Key Opinion Leader (KOL) engagement
  • Medico-marketing support for product campaign development & implementation
  • Supporting and training for diabetes sales teams
  • Medical support to brand team
  • Leverage local clinical trials— harvest potential synergies to support key business objectives
  • Driving and organizing advisory boards
  • Gather and report competitive data
  • Align on zonal objectives, strategy, and tactics
  • Share information individually or collectively during zonal meetings
  • Participate and facilitate medical session s in 'Begin, quarterly trainings

Senior Medical Scientific Liaison

Biocon Ltd
Bangalore
05.2013 - 05.2018
  • Medical Services, Biocon Metabolics
  • Dimensions:
  • KOLs identification & engagements

Medico-marketing Associate

Ranbaxy Labs Ltd
New Delhi
07.2010 - 05.2013
  • Managed multiple tasks simultaneously while maintaining attention to detail.

· Conducted:

o Observational study & Phase IV of new innovated molecules of Ranbaxy.

o Scientific & Medical Education Programme for Health Care professionals.

o Video interviews of KOLs for new innovated molecules of Ranbaxy.

· Developed:

o Short synopsis of research literatures /LBL Designing / Product monograph / PPT of NCE & related disease for discussion with health care professionals.

o Strong platform through pre-launching of NCE for Sales Team of Ranbaxy.

· Site selection, identified best Principal Investigator cum Customer (DRS), Monitoring pre-study, initiation, routine and close-out visits at investigator’s site as per SOPs/GCP, ADR/AE monitoring & reporting to same pharmacovigilance centre.

· Reviewed & developed protocols, CRFs and study related documents.

· Find out best customer (Drs) KOL, KBL through field survey analysis of Chemist, Path labs & Field Force.

· Arranged PI meetings for sharing scientific information of new molecule and trial related information.

· Successfully arranged National Scientific Conferences, Workshop, round table meeting (RTMs) for awareness of other health care professionals in specific territories.

Education

Doctor of Philosophy-PhD - A Study to Evaluate Functional Foot Care Practices in Patients with Diabetes Mellitus in Tertiary Care Centre Under Dr. Animesh Maiti (MD, DM), HOD, Department of Endocrinology & Metabolism

Calcutta Medical College
India

Masters in Business Administration - Healthcare Management

Bachelors in Pharmaceutical Sciences -

Skills

  • Medical strategy
  • Clinical trials
  • Regulatory compliance
  • KOL engagement
  • Medical education
  • Performance management

Languages

  • English
  • Bengali
  • Assamese
  • Hindi

Awards

  • 2023, OPPI India Runners-up award for best new product launch Rybelsus
  • 2022, Promoted to Senior Medical Manager, GLP-1 Portfolio, Novo Nordisk India Pvt Ltd.
  • 2021, Promoted to Medical Manager, GLP-1 Portfolio, North & East Region, Novo Nordisk India Pvt Ltd.
  • 2021, Recognized for outstanding medical contributions to Novo Nordisk India Pvt Ltd.
  • 2020, Invited Judge for the prestigious HRM-EBM course organized by St. John’s Medical College, Bengaluru.
  • 2019, Recipient of the 'Dr. David Sackett Memorial Award' for exceptional performance in Health Research Methodology and Evidence Based Medicine.
  • 2019, Awarded for the best oral presentation on 'Fast-tracking evidence generation in clinical trials' at the RMA 2.0 Bridge Meeting, Kuala Lumpur, Malaysia.
  • 2018, Recognized as Best Regional Medical Advisor for 2018 at Novo Nordisk India Pvt Ltd.
  • 2017, Awarded Best Medical Scientific Liaison (MSL) in the Metabolics Division, Biocon Ltd.
  • 2015, Promoted to Senior MSL, Medical Services, Biocon Metabolics Division for exceptional medical service delivery.

References

  • Dr. Romik Ghosh, Ex-Medical Director, Novo Nordisk India Pvt Ltd., +91-8792908793
  • Dr. Samir Hamid Zargar, Regional Director, APAC, Novo Nordisk, +91-8861586920
  • Dr. Guruprasad Thimmaiah, Ex-Army & Medical Affairs Head, Novo Nordisk India Pvt. Ltd, 09448899210

Disclaimer

10/01/24, Bangalore, Kingshuk Bhattacharjee

Personal Information

Marital Status: Married

Professional Summary

Senior Medical Manager with 14+ years of experience in the pharmaceutical industry, specializing in diabetes and metabolic diseases. Proven track record in driving product launches, leading medical affairs teams, and generating impactful real-world evidence. Expert in medical writing, biostatistics, and KOL management., Clinical Medical Regulatory Affairs, Leadership and Team Development, Medical Biostatistics, Strategic Thinking and Planning, Clinical Development and Evidence Generation

Languages

English
First Language

Certification

  • SAS 9.1

Accomplishments

1. Mohan V, Chawla M, Jothydev K, Kumar P, Bhattacharjee K, Nair A, Ghosh R. Real-world characterization of treatment intensified (add-on to metformin) adults with type 2 diabetes in India: A cross-sectional study (CONVERGE). Presented at the 14th World Congress of Diabetes India 2024, Bhubaneswar, Odisha, India, January 25-28, 2024.

2. Singh AK, Phatak SR, Singh R, Bhattacharjee K, Singh NK, Gupta A, Sharma A. Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study. Vaccine. 2021 Oct 22;39(44):6492-6509. doi: 10.1016/j.vaccine.2021.09.055. Epub 2021 Sep 24. PMID: 34600747; PMCID: PMC8461292

3. Anirban M, Soumyabrata RC, Debmalya S, Bhattacharjee K. Liraglutide – Indian experience. Indian J Endocr Metab 2018; 22:818-26

4. Kumar S, Sanyal D, Das P, Bhattacharjee K, Rungta R. An observational prospective study to evaluate the outcomes of new onset diabetes after renal transplantation (NODAT) in a tertiary care centre in eastern India. Diabetes Res Clin Pract. 2020 Jan; 159:107948. doi: 10.1016/j.diabres.2019.107948. Epub 2019 Nov 26.

5. Ghosh S, Pramanik S, Biswas K, Bhattacharjee K, Sarkar R, Chowdhury S, Mukhopadhyay P. Levothyroxine Absorption Test to Differentiate Pseudo-malabsorption from True Malabsorption. Eur Thyroid J 2020; 9:19–24 https://doi.org/10.1159/000504218

6. Mukhopadhyay P, Ghosh S, Bhattacharjee K, Chowdhury S. Inverse relationship between 25 hydroxy Vitamin D and parathormone: Are there two inflection points? Indian J Endocr Metab 2019; 23:422-7

7. Mukopadhyay S, Banerjee S, Bhattacharjee K. Correlation of Inflammatory Markers and Dyslipidemia with Carotid Intima-Media Thickness in Type 2 Diabetic Subjects. Journal of Clinical Diabetology. 2015; 2(1): 39-43

8. Roy Chaudhuri S, Majumder A, Sanyal D, Bhattacharjee K. Efficacy and Safety of Short-Term Usage of Insulin Co-Formulation (IDegAsp) in Treatment Naive Type 2 Diabetes Mellitus Patients, Presenting with Severe Hyperglycaemia and/ or Osmotic Symptoms-A Real World Observational Study. Diabetes Obes Int J 2018; 3(3): 1-9

9. Majumdar S, Gangopadhyay KK, Chaudhuri N, Ghosh Dastidar B, Dasgupta S, Majumder A and Bhattacharjee K. Barriers to Exercise in Type 2 DM Patients: An Institutional Cross-Sectional Descriptive Study. Journal of Diabetes, Metabolism and its Complications;2019: 1(1):2-11 doi: 10.31487/j.JDMC.2019.01.01

10. Sanyal D and Bhattacharjee K. Is there a need for a bisphosphonate drug holiday? Endocrinol Metab Int J. 2018;6(6):340‒346

11. Roy Chaudhuri S, Bhattacharya S, Chakraborty M, and Bhattacharjee K. “Serum Ferritin: A Backstage Weapon in Diagnosis of Dengue Fever,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2017, Article ID 7463489, 6 pages, 2017. doi:10.1155/2017/7463489

12. Ghosal S, Sinha B, Bhattacharjee K. Cardiovascular Outcomes Trials (CVOTs) with Anti-Hyperglycemic Agents: Demystifying Statistical Complexities. J Diabetes Metab Disord Control. 2017; 4(4): 00116. DOI: 10.15406/jdmdc.2017.04.00116

13. Chatterjee S, Majumder A, Ray S, Bhattacharjee K. Observational Study of Saroglitazar on Metabolic Parameters in Indian Patients with Diabetic Dyslipidaemia – A Fifty-Eight Weeks of Clinical Experience. Diabetes Obes Int J 2018, 3(3): 10-22.

14. Bhattacharjee K.A Review of Inferential Statistical Methods Commonly Used in Medicine. Journal of Clinical Diabetology. 2016; 3(2): 07-13

15. Roy N, Bhattacharjee K, Bandyopadhyay S et al. Role of Black Tea in Type 2 Diabetes Mellitus and Metabolic Syndrome. The Indian Journal of Nutrition and Dietetics. 2016;.53 (3): 354-59. DOI:10.21048/ijnd.2016.53.3.5341

16. Chakraverty C, Chakraborty S, Bhattacharjee K. Clinical profile of hepatitis B virus infection in patients attending tertiary care centre in eastern India. J. Evolution Med. Dent. Sci. 2016;5(37):2229-2233, DOI: 10.14260/jemds/2016/518

17. Roy N, Bhattacharjee K. Mechanism of action of Oral Anti-diabetic agents: A Review. Journal of Clinical Diabetology. 2016; 2(1): 39-43

18. Bhattacharjee K, Naikwadi SS. Maiti A. Barriers to Self-Foot Care Management in Type 2 Diabetes Mellitus Patients: An Institutional Cross-Sectional Descriptive Study in Eastern India. IJSRR2019; May-June.

19. Roy N, Bhattacharjee K, Saha AK. A strange case of hypoglycemia due to insulinoma in an Elderly female: An incomplete tale. International Journal of Clinical Cases and Investigations. 2015; 6 (3): 23-27.

20. Roy N, Saha AK, Jain K, Mukherjee S, Bhattacharjee K. Lemierre’s syndrome caused by Klebsiella pneumonia in an elderly diabetic male: An unusual aetiology. International Journal of Clinical Cases and Investigations. 2015; 6 (3): 17-22.

21. Sanyal D, Bhattacharjee K. A Case of Central Venous Sinus Thrombosis in Type 2 Diabetes with Severe Hypertriglyceridemia. Poster No: SAT-414. Presented at AACE Annual General Meeting, 2015

22. Pal SK, Santra T, Adhikari A, Bar M, Ranjan K and Bhattacharjee K. Clinical analysis on alteration of thyroid hormone in acute stroke patients and its effect on clinical outcome. European Journal of Biomedical and Pharmaceutical sciences. 2016; 3(5): 340-344

23. Chakraborty S, Sinha A, Dey L, Devarbhavi P and Bhattacharjee K. Effects of repeated pregnancies on left ventricular muscle mass in Indian population. EJBPS. 2016; 3(9): 300-305.

24. Sanyal D, Bhattacharjee K, Raichaudhry S. A Unique Case of Central Venous Sinus Thrombosis in Type 2 Diabetes with Severe Hypertriglyceridemia. Bangladesh Crit Care J March 2016; 4 (1): 58-60

25. Raichaudhry S, Cahkrabarti A, Bhattacharyya S and Bhattacharjee K. A Case Of Pleural Mass Presenting With Shortness Of Breath And Refractory Non-Insulin Mediated Hypoglycaemia. EJBPS. 2016; 6(12): 500-505

26. Chaudhuri SR, Majumder A, Sanyal D, Bhattacharjee K (2016) LIRA 365 Plus-A Real World Experience of 19 Months Use of Liraglutide in the Obese Indian Type 2 Diabetic Subjects. Adv Obes Weight Manag Control 5(4): 00136. DOI: 10.15406/aowmc.2016.05.00136

27. Chaudhuri SR, Sanyal D, Majumder A, Bhattacharjee K. Short Term Outcomes of Low Dose Liraglutide in Obese Non-Diabetic Indian Subjects-A Real World Experience. Diabetes Obes Int J 2016,1(7): 000140.

28. Sinha A, Bhattacharjee K, Halder A, Sinha P, Verma A, (2016). Effect of Metformin on Serum Thyrotropin (Thyroid Stimulating Hormone) Levels in Hypothyroid Patients on Stable and Adequate Levothyroxine Doses with Diabetes or Pre-Diabetes. J Endocrinol Diab. 3(6): 1-5.

29. Das TC, Maiti A, Basu AK, Sinha A, Dey L, Devarbhavi P, Chakraborty S, Swar S, Sinha N, Bhattacharjee K. Adrenal histoplasmosis in an immunocompetent Individual– a rare case report. Int J Med Res Rev 2016; 4(10): 1773-1777.doi:10.17511/ijmrr. 2016.i10.11.

30. Chatterjee S, Ray S, Majumder A, Bhattacharjee K. Effects on metabolic parameters of addition of sglt-2 inhibitors on patients with type 2 diabetes inadequately controlled with dpp-iv inhibitors and metformin. Diabetes Technology & Therapeutics. Diabetes Technology & Therapeutics. 2017, 19(S1): A-1-A-133.

31. Roy N, Bhattacharjee K, Gupta E. A study to evaluate different conditions leading to diagnosis of T2DM in a tertiary care hospital in Eastern India. Int J Adv Med 2017; 4:166-9.

32. Swar SC, Chakraborty K, Das MK, Roy AC and Bhattacharjee K. Study on the association between hyperuricemia & albuminuria in patients with type 2 diabetes mellitus. International Journal of Endocrinology & Metabolism Research. 2017;2(1):01-09.

33. Roy Chaudhuri S, Das D, Bhattacharya S, Chakraborty S, and Bhattacharjee K. Hyper Homocysteinemia Related Cerebral Venous Sinus Thrombosis –Presenting as Generalised Tonic-Clonic Seizure –A Case Report. International Journal of Clinical and Experimental Neurology, 2017; 5(1): 5-8. doi: 10.12691/ijcen-5-1-2.

34. Devarbhavi P, Maiti A, Singha A, Basu AK, Chakraborty S, Dey L, Swar S, Bhattacharjee K. Rituximab therapy in steroid resistant thyroid associated ophthalmopathy. Case Rep Int 2017;6:01-07

35. Swar S and Bhattacharjee K. A rare case of DSD diagnosed as Swyer Syndrome. International Journal of current research. Vol. 9, Issue, 06, pp.52671-52674

36. Roy Chaudhuri S, Das D, Dasgupta H, Mukherjee D, and Bhattacharjee K, “A Probable Case of Scrub Typhus Meningoencephalitis – In the Era of Dual Seropositivity and Possible Emerging Doxycycline Resistance - Are Dictums Changing?” American Journal of Medical Case Reports, vol. 5, no. 3 (2017): 69-76. doi: 10.12691/ajmcr-5-3-7.

37. Sanyal D, Das P, Gupta S, Bhattacharjee K. Evaluation of Pre-Transplant Risk Factors as Independent Predictors on the New Onset of Diabetes after Renal Transplants (NODAT). J Endocrinol Thyroid Res. 2017; 2(1): 555576

38. Majumder A and Bhattacharjee K. Beginning with Very Low Dose (0.2mg) Liraglutide in Indian Type 2 Diabetic Patients Appears Better Tolerated: Experience from Real Life Practice. J Diabetes Metab Disord Control 4(6): 00127. DOI: 10.15406/jdmdc.2017.04.00127

39. Mukhopadhyay P, Roy Chaudhuri S, Maiti A, Ruj Maiti S, Bhattacharjee K. Efficacy and Safety of Short-Term Biosimilar Insulin Glargine Therapy in Drug Naïve New Onset Type 2 Diabetes Mellitus Patients presenting with Severe Hyperglycemia. Indian Medical Gazette. 2017; 8: 1-8

40. Bhattacharjee K, Majumder A, Roychoudhury S, Sanyal D, Mukhopadhyay P. Study of real-life safety and efficacy of insulin glargine in T2DM patients with established chronic kidney disease. In: Proceedings of the IDF Congress 2017; Dec 4-8, 2017; Abu Dhabi. Abstract P-0350. Available at http://conference.idf.org/IDF2017/abstracts/data/HtmlApp/main.html#16. Accessed on 20/02/2018

41. Bhattacharyya S, Bhattacharyya S, Bhattacharjee K. Saroglitazar and its impact on Diabetic Dyslipidaemia: A Real-life Observational study from Eastern India. Indian Journal of Basic and Applied Medical Research; March 2018: Vol.-7, Issue- 2, P. 298-303

42. Chakraborty S, Maiti A, Sinha A, Dey L, Basu A, Bhattacharjee K. Association of degree of insulin resistance with retinal nerve fibre layer thickness in metabolic syndrome, pre-diabetics, obese PCOD & newly diagnosed type 2 diabetes. JIMA. 2017; 115 (11): 57-63

43. Bhattacharyya S, Bhattacharyya S, Bhattacharjee K.Evaluation of blood lipid parameters in type 2 diabetes mellitus subjects and its correlation with glycosylated hemoglobin: a prospective study from Eastern India. Indian Journal of Basic and Applied Medical Research; March 2017: Vol.-6, Issue- 2, P. 696-701

44. Roy Chaudhuri S, Majumder A, Sanyal D and Bhattacharjee K. Efficacy and Safety of Short-Term Usage of Insulin Co-Formulation (IDegAsp) in Treatment Naive Type 2 Diabetes Mellitus Patients, Presenting with Severe Hyperglycemia and/ or Osmotic Symptoms-A Real World Observational Study. Diabetes Obes Int J 2018; 3(2): 000179

45. Chatterjee S, Majumder A, Ray S and Bhattacharjee K. Observational Study of Saroglitazar on Metabolic Parameters in Indian Patients with Diabetic Dyslipidaemia – A Fifty-Eight Weeks of Clinical Experience. Diabetes Obes Int J 2018; 3(2): 000180

46. Mukhopadhyay P, Ghosh S, Bhattacharjee K, Pandit K, Mukherjee PS, Chowdhury S. Lean metabolic syndrome: A concept or a reality? Indian J Endocr Metab 2018; 22:303-7.

47. Mandal B, Shukla R, Basu AK, Sinha A, Maiti A, Bhattacharjee K et al. (2018) Association of ABO Blood Groups with Type-2 Diabetes Mellitus and its Complications. J Diabetes Metab Disord Control 5(1): 00130. DOI: 10.15406/jdmdc.2018.05.00130

48. S Kumar S, Sanyal D, Das P, Bhattacharjee K, Rungta R. A Real-World Prospective Study to Evaluate the Preoperative Risk Factors of New‑onset Diabetes Mellitus after Renal Transplantation in a Tertiary Care Centre in Eastern India. Indian J Endocr Metab 2018; 23: 18-29

49. Roy S, Bhattacharjee K (August 13, 2019) A Cross-sectional Retrospective Analysis of Glycemic Burden and Nephropathy in an Indian Population and Formulation of a New Plan Using eGFR/HbA1c Grid Formation. Cureus 11(8): e5378. doi:10.7759/cureus.5378

50. Malawat A, Chakrabarti P, Bhattacharjee K, Ghosh S and Mukhopadhyaya P. Periodontal disease in Type 2 Diabetes. JIMA Special Issue. 2020; Oct: 11-18

51. Bhattacharjee K, Naikwadi SS, Maiti A. Knowledge, attitude and practice towards self-foot care management in patients with type 2 diabetes mellitus: an institutional based cross-sectional descriptive study. IJAR. 2019; 9(7): 65-68

52. Bhattacharjee K, Ruj Maiti S, Maiti A.A study to evaluate self-foot care behaviour in Indian patients with type 2 diabetes mellitus. IJAR. 2019; 9(11): 1-2

53. Bhattacharjee K, Naikwadi SS, Maiti A. Barriers to Self-Foot Care Management in Type 2 Diabetes Mellitus Patients: An Institutional Cross-Sectional Descriptive Study in Eastern India. IJSRR 2019, 8(2), 3009-3021

54. Pramanik S, Mukhopadhyay P, Bhattacharjee K, Bhattacharjee R, Mukherjee B, Mondal SA, et al. Trimester-specific reference intervals for thyroid function parameters in Indian pregnant women during final phase of transition to iodine sufficiency. Indian J Endocr Metab 2020; 24:160-4.

55. Ray S, Mitra A, Bhattacharjee K. Prevalence of vitamin D deficiency among health care professionals in a medical college of India. J Diab Metab Disorder Control. 2020;7(2):42‒45. DOI: 10.15406/jdmdc.2020.07.00198

56. Kumar S, Sanyal D, Das P, Bhattacharjee K, Rungta R. An observational prospective study to evaluate the preoperative risk factors of new-onset diabetes mellitus after renal transplantation in a tertiary care centre in Eastern India. Indian J Endocr Metab 2018; 22:610-5

57. Sanyal D, Bhattacharjee K, Das P. A new scoring system to predict the incidence of New Onset Diabetes after Transplantation (NODAT). Clinical Diabetology 2020;9(4):226-232

58. Sanyal D, Bhattacharjee K. New-Onset Diabetes after Renal Transplantation (NODAT): Risks & Risk Factors. Current Research in Diabetes & Obesity Journal, 2019;10 (3): 1-2

59. Majumder A, Roychaudhuri S, Chakraborty S, Bhattacherjee K. An observational study of the quality of life among gender incongruent individuals from “Hijra” Community of India. Indian J Endocr Metab 2020; 24:301-5

60. Roy S, Majumder P, Bhattacharjee K. A pilot study to see any Change of the Nasal and Oropharyngeal Microbiota with Prolonged Use of Medical Masks during the COVID-19 Outbreak. medRxiv 2020.08.15.20175067; doi: https://doi.org/10.1101/2020.08.15.20175067

61. Sanyal D, Bhattacharjee K. High thyroid stimulating hormone level in Down’s Syndrome: A mere resetting of hypothalamopituitary axis in subclinical hypothyroidism. Indian J Endocr Metab 2020; 25:441-6

62. Roy S, Bhattacharjee K. Effect of Screen time on Glycaemic control of Type 2 Diabetes patients during COVID-19 Outbreak: A Survey based Study. medRxiv 2020.09.09.20188961; doi: https://doi.org/10.1101/2020.09.09.20188961

63. Chakraborty P, Mukhopadhyay P, Bhattacharjee K, Chakrabarti A, Ghosh S and Chowdhury S. Periodontal Disease in Type 1 Diabetes Mellitus: Influence of Pubertal Stage & Glycemic Control. Endocr Pract. 2021 Jan 21;S1530-891X(21)00016-1. doi: 10.1016/j.eprac.2021.01.010.

64. Roy S, Samajdar S, Tripathi SK, Mukherjee S and Bhattacharjee K. Outcome of Different Therapeutic Interventions in Mild COVID-19 Patients in a single OPD Clinic of West Bengal: A Retrospective Study. medRxiv preprint doi: https://doi.org/10.1101/2021.03.08.21252883

65. Singh AK, Phatak S, Singh NK, Gupta A, Sharma A, Bhattacharjee K, Singh R. Antibody Response after First-dose of ChAdOx1-nCOV (Covishield) and BBV-152 (Covaxin) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study. medRxiv 2021.04.07.21255078; doi: https://doi.org/10.1101/2021.04.07.21255078

66. Majumdar S, Sinha B, Dastidar BG, Gangopadhyay KK, Ghoshal S, Mukherjee JJ, Mazumdar A, Ray S, Dasgupta S, Bhattacharjee K. Assessing prevalence and predictors of depression in Type 2 Diabetes Mellitus (DM) patients - The DEPDIAB study. Diabetes Res Clin Pract. 2021 Jul 28; 178:108980. doi: 10.1016/j.diabres.2021.108980. Epub ahead of print. PMID: 34329694.

References

References available upon request.

Timeline

Senior Medical Manager

Novo Nordisk India Pvt Ltd
08.2022 - Current

Medical Manager

Nordisk India Pvt Ltd
10.2021 - 07.2022

Regional Medical Advisor

Novo Nordisk India Pvt Ltd
06.2018 - 09.2021

Senior Medical Scientific Liaison

Biocon Ltd
05.2013 - 05.2018

Medico-marketing Associate

Ranbaxy Labs Ltd
07.2010 - 05.2013

Doctor of Philosophy-PhD - A Study to Evaluate Functional Foot Care Practices in Patients with Diabetes Mellitus in Tertiary Care Centre Under Dr. Animesh Maiti (MD, DM), HOD, Department of Endocrinology & Metabolism

Calcutta Medical College

Masters in Business Administration - Healthcare Management

Bachelors in Pharmaceutical Sciences -

Similar Profiles

CREATE PROFILE
Kingshuk Bhattacharjee